(Q46309681)

21 December 2017

title

Seroprevalence of anti-N-methyl-D-aspartate receptor antibodies in women with ovarian teratoma (English)

1 reference

21 December 2017

0 references

6

1 reference

21 December 2017

author name string

Mandy Mangler

1

1 reference

21 December 2017

Isabel Trebesch de Perez

2

1 reference

21 December 2017

Bianca Teegen

3

1 reference

21 December 2017

Winfried Stöcker

4

1 reference

21 December 2017

Harald Prüss

5

1 reference

21 December 2017

Achim Schneider

7

1 reference

21 December 2017

Jekaterina Vasiljeva

8

1 reference

21 December 2017

Dorothee Speiser

9

1 reference

21 December 2017

publication date

24 August 2013

1 reference

21 December 2017

published in

Journal of Neurology

1 reference

21 December 2017

volume

260

1 reference

21 December 2017

issue

11

1 reference

21 December 2017

page(s)

2831-2835

1 reference

21 December 2017

https://scigraph.springernature.com/pub.10.1007/s00415-013-7074-0

exact match

0 references

cites work

Paraneoplastic anti-N-methyl-D-aspartate receptor encephalitis associated with ovarian teratoma

1 reference

https://api.crossref.org/works/10.1007%2FS00415-013-7074-0

Expression of various glutamate receptors including N-methyl-D-aspartate receptor (NMDAR) in an ovarian teratoma removed from a young woman with anti-NMDAR encephalitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-013-7074-0

Evidence for antibody-mediated pathogenesis in anti-NMDAR encephalitis associated with ovarian teratoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-013-7074-0

Pseudo-piano playing motions and nocturnal hypoventilation in anti-NMDA receptor encephalitis: response to prompt tumor removal and immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-013-7074-0

Anti-NMDA receptor encephalitis in Japan: long-term outcome without tumor removal.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-013-7074-0

Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-013-7074-0

Anti-NMDA receptor encephalitis: a cause of acute psychosis and catatonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-013-7074-0

Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-013-7074-0

Reversible brain atrophy in anti-NMDA receptor encephalitis: a long-term observational study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-013-7074-0

A patient with encephalitis associated with NMDA receptor antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-013-7074-0

Anti-NMDA-receptor encephalitis: a severe, multistage, treatable disorder presenting with psychosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-013-7074-0

Anti-NMDA-receptor encephalitis. An interdisciplinary clinical picture

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-013-7074-0

[Dramatic improvement in two cases of anti-NMDA receptor encephalitis after immunomodulating therapy].

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-013-7074-0

Anti-NMDA receptor encephalitis. The disorder, the diagnosis and the immunobiology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-013-7074-0

Analysis of complement and plasma cells in the brain of patients with anti-NMDAR encephalitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-013-7074-0

Prevalence and treatment of anti-NMDA receptor encephalitis – Authors' reply

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-013-7074-0

N-methyl-D-aspartate antibody encephalitis: temporal progression of clinical and paraclinical observations in a predominantly non-paraneoplastic disorder of both sexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-013-7074-0

Increased prevalence of diverse N-methyl-D-aspartate glutamate receptor antibodies in patients with an initial diagnosis of schizophrenia: specific relevance of IgG NR1a antibodies for distinction from N-methyl-D-aspartate glutamate receptor encepha

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-013-7074-0

N-methyl-D-aspartate receptor antibodies in herpes simplex encephalitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-013-7074-0

Retrospective analysis of NMDA receptor antibodies in encephalitis of unknown origin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-013-7074-0

Diagnostic value of N-methyl-D-aspartate receptor antibodies in women with new-onset epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-013-7074-0

A Case of New Onset Psychosis in a Young Woman with Minimal Response to Risperidone, Ultimately Diagnosed with N-Methyl-D-Aspartate Receptor Encephalitis: A Review of this Under-Recognized Condition

21 January 2018

1 reference

12 December 2020

Anti-N-methyl-D encephalitis

1 reference

12 December 2020

Ovarectomy despite Negative Imaging in Anti-NMDA Receptor Encephalitis: Effective Even Late

1 reference

12 December 2020

Antiepileptic treatment for anti-NMDA receptor encephalitis: the need for video-EEG monitoring.

1 reference

12 December 2020

Therapeutic plasma exchange in anti-N-methyl-D-aspartate-receptor (anti-NMDA-R) encephalitis associated with benign ovarian teratoma

1 reference

12 December 2020

[Autoantibody diagnostics in neurology using native and recombinant antigenic substrates]

1 reference

12 December 2020

10.1007/S00415-013-7074-0

Identifiers

DOI

1 reference

21 December 2017

PubMed ID

23979101

1 reference

21 December 2017